Liver cancer accounts for approximately 64%¹ of all Interventional Oncology procedures and Cone Beam CT is proven to improve the feasibility, effectiveness, and safety of challenging interventions.² GE’s comprehensive Liver Care solutions are engineered to enable physicians to access the full potential of Cone Beam CT images within their daily practice by removing the most common barriers that stand along the course of their minimally invasive liver treatment.

From acquisition to application, through final assessment, GE's complete Liver Care portfolio supports excellence in endovascular and percutaneous procedures by enabling:

High-quality Cone Beam CT acquisitions with Discovery IGS 7³ (wide bore gantry, 41 cm² detector).

Compensation for involuntary respiratory motion artifacts that threaten Cone Beam CT quality with exclusive Motion Freeze solution.⁴

Precise planning and embolization guidance with Liver ASSIST.⁵ Liver ASSIST provides a high sensitivity in detecting liver tumor feeding vessels. It improves the sensitivity of tumor-feeding vessels identification to reach up to 97-percent.^{11, 12, 13} It has demonstrated ~68% complete tumor response rate (vs. 36% with DSA alone)¹⁴

Automatic fusion between ultrasound⁷ and Cone Beam CT as well as other pre-operative images using INTERACT Active Tracker.⁶

Real-time visualization of needle positions in the 3D space with Needle ASSIST to help you improve your accuracy, reduce dose and support efficiency efforts when performing needle interventions⁸ in the angio suite.

The combined capabilities of GE's Liver Care portfolio equip clinical teams to confidently access and leverage Cone Beam CT in even the most challenging procedures for endovascular and needle-based treatments.